Caffeine Caplets
Caffeine Caplets, licence 80004918: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Haleon Canada ULC
- NPN or DIN-HM
- 80004918
- Status
- Inactive licence
- Licence date
- 18 January 2008
- Revision date
- Not provided
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hypromellose, Starch, Corn, FD & C bleu #1, Acide benzoïque, Saccharose, propylèneglycol, Poly(sorbate) 20, Cire de Carnauba, Povidone, Cellulose - microcrystalline, Mineral oil, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Caplet | Not specified |
Uses authorised in Canada
Helps to temporarily promote alertness and wakefulness, and to enhance cognitive performance. Helps to temporarily to relieve fatigue, to promote endurance, and to enhance motor performance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have high blood pressure, glaucoma and/or detrusor instability (overactive bladder syndrome). For a dose >300 mg per day Consult a health care practitioner if you are a child bearing age, pregnant or breastfeeding and at doses >600 mg per day, caffeine may cause anxiety, tachycardia (rapid heart rate), palpitations, insomnia, restlessness, nervousness, tremor and headache. Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine) ephedra or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consult a health care practitioner prior to use if you are taking lithium. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep.
Source
Official Health Canada record, licence 80004918
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.